UniSuper Management’s Edwards Lifesciences EW Stock Holding History

UniSuper Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.26M	Sell	53,171 -1,697	-3%	-$140K	0.03%	291
2025 Q4	$4.68M	Sell	54,868 -9,163	-14%	-$752K	0.03%	272
2025 Q3	$4.98M	Buy	64,031 +14,695	+30%	+$1.15M	0.03%	282
2025 Q2	$3.86M	Sell	49,336 -2,709	-5%	-$202K	0.03%	296
2025 Q1	$3.77M	Buy	52,045 +1,400	+3%	+$100K	0.03%	288
2024 Q4	$3.75M	Sell	50,645 -198,501	-80%	-$13.9M	0.03%	281
2024 Q3	$16.4M	Buy	249,146 +209,634	+531%	+$15.2M	0.12%	125
2024 Q2	$3.65M	Buy	39,512 +21,442	+119%	+$1.9M	0.03%	254
2024 Q1	$1.73M	Sell	18,070 -48,754	-73%	-$4.1M	0.02%	285
2023 Q4	$5.1M	Sell	66,824 -3,795	-5%	-$264K	0.06%	179
2023 Q3	$4.89M	Sell	70,619 -1,052	-1%	-$84.5K	0.06%	176
2023 Q2	$6.76M	Buy	+71,671	New	+$6.23M	0.08%	157

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UniSuper Management's EW Position: Q1 2026 in Review

UniSuper Management reduced its Edwards Lifesciences (EW) stake by 3.1% in Q1 2026, selling an estimated $140K and leaving 53,171 shares worth $4.26M. The position accounts for 0.03% of the portfolio, ranked #291.

UniSuper Management first reported a position in EW in Q2 2023 and has held it in 12 quarters since. The position peaked at $16.4M in Q3 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

UniSuper Management held 53,171 shares of Edwards Lifesciences worth $4.26M as of Q1 2026.
UniSuper Management sold 1,697 Edwards Lifesciences shares in Q1 2026, an estimated $140K.
Edwards Lifesciences made up 0.03% of UniSuper Management's portfolio in Q1 2026, its #291 holding.
UniSuper Management first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 12 quarters since.
UniSuper Management's Edwards Lifesciences position peaked at $16.4M in Q3 2024.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.